JC

James Corbett

Mr Corbett was appointed as President and CEO of the Company effective as of September 28, 2022. Mr Corbett served as a Non-Executive Director from July 2021 to September 28, 2022. He has approximately 40 years of leadership experience in the medical device field, most recently, as CEO of CathWorks Ltd., a software-based medical technology company. Mr Corbett has global commercial and operating experience, serving as an expatriate General Manager of Baxter Japan and later as General Manager and President of Scimed Life Systems Inc. and Boston Scientific International respectively. During his career he has served as CEO of three publicly listed companies; Microtherapeutics Inc (MTIX), ev3 Inc (evvv), Alphatec Spine (ATEC). Mr. Corbett has also led two privately funded companies as CEO: Home Diagnostics Inc. and Vertos Medical.

Holding

Company
Last Notice
Direct Shares
Indirect Shares
Options
Convertibles
AVH
AVH
27/12/238,689N/A333,771N/A

Transactions

Company
Date
Type
Amount
Price
Value
Notes
AVH
AVH
06/06/24
Issued
350,000$2.830$990,500Issue of options
AVH
AVH
27/12/23
Sell
1,445$4.170$6,025As advised by the company
AVH
AVH
07/06/23
Issued
100,000$4.290$429,000Issue of options
AVH
AVH
23/12/22
Buy
7,242$2.010$14,556Conversion of securities
AVH
AVH
23/12/22
Exercise
7,242$2.010$14,556Conversion of securities